-
Novel PLA2G6 c.1627C>T homozygous mutation and response to DBS-GPi
-
Novel mutations identified in dopamine transporter deficiency syndrome
-
Novel PET Tracers of alpha-synuclein for the diagnosis of Parkinson’s disease
-
Novel small molecules targeting alpha-synuclein aggregation for the treatment of Parkinson’s disease
-
Novel THAP1 missense mutation leading to focal and segmental dystonia
-
Novel training based on declarative memory cues improves gait perfromance in patients with Parkinson’s disease: A randomized clinical trial
-
Novel variants in the SACS gene in a first Central-Eastern European family with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)
-
NREM parasomnias as a marker of cognitive impairment in Parkinson’s disease
-
Nursing diagnoses and interventions in rehabilitation related to antiParkinsonian pharmacotherapy
-
Nutritional status and quality of life in patients with Parkinson’s disease in a tertiary hospital in Northeast Mexico
- « Previous Page
- 1
- …
- 132
- 133
- 134
- 135
- 136
- …
- 207
- Next Page »